| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |